Reduction of Masseter Muscle Prominence After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period in Europe

Authors
Category Primary study
ConferenceTOXINS 2026 8th International Conference
Year 2026
This article has no abstract
Epistemonikos ID: e453e047df73659f246fdc5eeae057c8a20a1819
First added on: Feb 16, 2026